AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Angelo Vanzulli

Angelo Vanzulli

Ospedale Niguarda Ca' Granda, Milan - Milano / Italy
Others
AD Scientific Index ID: 4984852
person_outline Angelo Vanzulli's MOST POPULAR ARTICLES
1-) Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of … The Lancet Oncology 17 (6), 738-746, 2016
2-) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type … Diabetes 48 (8), 1600-1606, 1999
3-) Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1) Cancer discovery 7 (4), 400-409, 2017
4-) Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial Nature Medicine 28 (8), 1612-1618, 2022
5-) Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19-9 assessment, US, CT, and CT-guided fine-needle biopsy. Radiology 178 (1), 95-99, 1991